Olaf Sporns

Title: The Innovations of Olaf Sporns

Introduction

Olaf Sporns is a prominent inventor based in San Diego, CA. He is known for his significant contributions to the field of neuroscience, particularly in the area of glial cell proliferation. His work has implications for understanding neural development and potential therapeutic approaches.

Latest Patents

Olaf Sporns holds a patent titled "Inhibition of glial cell proliferation with N-CAM homophilic peptides." This patent discloses methods and compositions that are useful for inhibiting glial cell proliferation by binding inhibiting agents to neural cell adhesion (N-CAM) molecules present on the cell surface. The inhibiting agents can include peptides derived from the homophilic binding region of N-CAM, monoclonal antibodies, polyclonal antibodies, and Fab' fragments. Notably, the exemplary N-CAM homophilic peptides consist of 7 to 90 amino acid residues, featuring a positively charged amino acid residue separated from a negatively charged amino acid residue by five intervening amino acid residues. Olaf Sporns has 1 patent to his name.

Career Highlights

Olaf Sporns is affiliated with the Scripps Research Institute, where he has made significant strides in his research. His work has contributed to a deeper understanding of neural mechanisms and has potential applications in treating neurological disorders.

Collaborations

Throughout his career, Olaf has collaborated with notable scientists, including Kathryn L Crossin and Gerald M Edelman. These collaborations have enriched his research and expanded the impact of his findings in the scientific community.

Conclusion

Olaf Sporns is a distinguished inventor whose work in neuroscience has led to valuable insights and innovations. His patent on inhibiting glial cell proliferation showcases his commitment to advancing the field and improving our understanding of neural processes.